Immune checkpoint inhibitor integration in locoregionally advanced nasopharyngeal carcinoma: a prospective evidence synthesis on efficacy, safety, and therapeutic optimization.

gemcitabine - Generic mfg.

cisplatin - Generic mfg.

AiRuiKa (camrelizumab) - Elevar Therapeutics

Loqtorzi (toripalimab-tpzi) - Shanghai Junshi Bioscience, Coherus Oncology

http://www.ncbi.nlm.nih.gov/pubmed/42433378

Chen Han; Hui Xie; Lian Jian; Peng Chen; Yaqian Han; Ying Jiang; Yu Gong; Ziying Zhang

Jul 12, 2026